Guest blog post by Dr Carlo Galli, author of a timely Commentary published in Journal of Negative Results in BioMedicine, which discusses the debate surrounding seratonin in the treatment of bone loss in periodontitis. He argues that although contradictory, recent findings may lead the way to novel treatment opportunities for periodontitis and similar bone loss. One of the crucial aspects… Read more »
Launching today with BioMed Central is Basic and Clinical Andrology, a continuation of the French journal Andrologie, which was previously published as a subscription journal by Springer in French. The journal will now be open access and published in English. In keeping with its French past the journal will also publish the abstracts of articles… Read more »
Alzheimer’s Research & Therapy is accepting research submissions for consideration in a special series on tau-based therapeutic strategies for Alzheimer’s disease and related dementias. There is great interest in finding therapeutics to reverse or remove tau aggregates from the human brain. Pathological aggregation of tau protein is associated with many neurodegenerative diseases, termed ‘tauopathies’, the… Read more »
BMC Medicine published the results of a study by Frank Duffy and colleagues on EEG signatures in children with Asperger’s and autism on July 31st as part of our Current Controversies in Psychiatry article collection.
As low- and middle- income countries (LMICs) continue to face health challenges from infectious disease, they are concurrently challenged by the rising burden of non-communicable diseases including cancer. The International Agency for Research on Cancer (IARC) estimates that by 2030, the annual number of new cancer cases worldwide will exceed 21 million and the number… Read more »
“Industry and academics must share all trial results: without this information, doctors are misled, and patients are harmed.” That’s Ben Goldacre summing up the motivation behind the campaign AllTrials, and yes, it’s just that simple. Launched in January 2013, AllTrials is an initiative on behalf of Sense about Science, Bad Science, the BMJ, and others… Read more »
In September last year, the National Football League (NFL) pledged to provide $30 million in funding for medical research, the single-largest donation to any organization in the league’s 92-year history. One of the main research areas for the funding, overseen by The National Institutes of Health (NIH), is chronic traumatic encephalopathy (CTE) and the link… Read more »
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gut that causes pain and diarrhea. The most common forms of IBD are Crohn’s disease and ulcerative colitis. In the majority of patients these conditions can be well-controlled with medication, but surgery is sometimes required if treatment is not effective. Given the rising incidence… Read more »
Accelerating the development of innovative treatments for Alzheimer’s disease and related dementias is the target for scientists brought together at the 14th International Conference on Alzheimer’s Drug Discovery, and the focus of a special thematic series in Alzheimer’s Research & Therapy. Hosted by the Alzheimer’s Drug Discovery Foundation (ADDF), on 9 – 10 September 2013… Read more »
Looking back at BMC Medicine’s article collection